Skip to main content
. 2022 Aug 2;12:822805. doi: 10.3389/fonc.2022.822805

Figure 6.

Figure 6

In vivo antitumor effect of iRGD-Exos-BCL6 siRNA. (A, B) Firefly luciferase expressing OCI-Ly8 cells were injected into the nude mice via tail vein, and then mice were intravenously injected with PBS, iRGD-Exo-siNC, blank-Exo-BCL6 siRNA (blank-Exo-siRNA) and iRGD-Exo-BCL6 siRNA (iRGD-Exo-siRNA). Luciferase activity at days 10, 20 and 40 after cancer cell injection was detected. *P < 0.05, **P < 0.01.